Company Disclosure
Corona Remedies Limited (Scrip Code: 544644 on BSE, Symbol: CORONA on NSE) submitted a regulatory filing to both stock exchanges on August 03, 2026.
Document Context
This letter serves as a continuation to the company's previous communication dated July 22, 2026 regarding the same matter.
Content Details
The earnings conference call discussed the unaudited financial results of the Company for the first quarter and three months ended June 30, 2026.
Availability Information
The audio recording is available on the company's website at: https://www.coronaremedies.com/q1-fy27-epcar
Company Representative
The letter was digitally signed by Chetna Prabhat Kumar Dharajiya, who holds the position of Company Secretary and Compliance Officer of Corona Remedies Limited.
Timestamp
The digital signature was dated August 03, 2026 at 16:02:47 IST (GMT+5:30).